Investor · New York, NY

David J. Schubert

Open David in the network graph →

Filings

33

SEC Form D

Connections

151

co-filers

Capital

$123.3M

across filings

Active

Dec 2013

to Jul 2024

Most-connected co-filers (151)

Joel J. Marcus · New York, NY24 shared Barbara J. Dalton · New York, NY21 shared Lindsay J. Rayle · New York, NY18 shared David J. Mcelligott · New York, NY18 shared M. J. Erwin · New York, NY18 shared Thong Le · New York, NY18 shared Steve T. Gillis · Cambridge, MA11 shared Christopher Y. Thorne · New York, NY10 shared Paul Watson · Houston, TX10 shared James Sullivan · Berkshire, United Kingdom9 shared Stephen A. Herrod · Palo Alto, CA7 shared Ibis Investments, LLC · New York, NY7 shared Ibis Management, LLC · New York, NY7 shared Andrew V. Sheehan · San Mateo, CA6 shared Ajit Sancheti · San Francisco, CA6 shared David P. Bordo · McMurray, PA6 shared Matthew R. Gottesdiener · Newton, MA6 shared Gordon L. Roth · Newport Beach, CA6 shared Clifford M. Weiner · Dallas, TX6 shared Erik W. Anderson · Costa Mesa, CA6 shared Robert O. Tatum, Jr · Hattiesburg, MS6 shared Misti R. Ushio · Gaithersburg, MD6 shared Kerwin Brandt · CHICAGO, IL6 shared Suzanne D. Abair · Newton, MA6 shared

Recent filings (33)

IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2024 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2023 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2022 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2021 · 5 co-filers IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2020 · 5 co-filers Petra Pharma CorpMar 2020 · 34 co-filers$27.5M Petra Pharma CorpOct 2019 · 34 co-filers$23.0M Accolade, Inc.Oct 2019 · 38 co-filers$20.0M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2019 · 3 co-filers Petra Pharma CorpApr 2019 · 34 co-filers$13.3M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2018 · 3 co-filers Accolade, Inc.Mar 2018 · 44 co-filers$50.0M Petra Pharma CorpJan 2018 · 34 co-filers$48.3M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2017 · 3 co-filers Petra Pharma CorpJan 2017 · 25 co-filers$48.3M Lodo Therapeutics CorpJan 2017 · 31 co-filers$19.9M Accolade, Inc.Aug 2016 · 31 co-filers$60.0M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2016 · 5 co-filers eTouches, Inc.May 2016 · 14 co-filers$20.0M Petra Pharma CorpJan 2016 · 28 co-filers$10.4M Lodo Therapeutics CorpJan 2016 · 29 co-filers$3.7M Accolade, Inc.Dec 2015 · 31 co-filers$53.6M Accolade, Inc.Jul 2015 · 30 co-filers$35.0M IBIS SPECIAL OPPORTUNITIES FUND, LPJul 2015 · 5 co-filers Boyd Watterson Ltd Duration Mid-Grade Fund, LLCJul 2015 · 20 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See David in the interactive graph →